FedEx, Sarepta Therapeutics and more
Engineers move a 350-volt battery pack to be installed in a Fedex Corp. Express General Motors Co. (GM) van at the VIA Motors Inc. facility in Orem, Utah, USA on Monday, February 17, 2014.
George Frey | Bloomberg | Getty pictures
Here are the stocks that make headlines after the clock.
FedEx ̵[ads1]1; Shares in the shipping company rose more than 3% after FedEx provided positive guidance for the full financial year, and estimates an increase in adjusted earnings. FedEx reported mixed results for its recently closed fourth quarter accounting, with $ 6.87 in adjusted earnings per share of $ 24.39 billion in revenue. Analysts surveyed by Refinitiv expected $ 6.86 in earnings per share of $ 24.56 billion in revenue.
Sarepta Therapeutics – Biopharma shares fell more than 5% in expanded trading after the FDA put a clinical grip on Sarepta’s treatment for Duchenne muscular dystrophy. Sarepta said there was a “serious side effect” in one of the treatment studies.
Smith & Wesson Brands – Shares of the firearms manufacturer fell around 2% after Smith & Wesson’s fourth quarter financial report showed a decline in revenue and gross margin from year to year. The company, which has a market value of approximately $ 650 million, increased its quarterly share to 10 cents per share from 8 cents.
